Rawzi Baik
Optometrist · Cincinnati, OHNPI 1548613391
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,634 of the $14,454 with a category attached, or 66.7%. It is spread thinly across 20 manufacturers, the largest accounting for just 20.4%. Reporting peaked in 2019 at $6,559 and has fallen 89.2% since, to $705 in 2025. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $60.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$3K
- Alcon$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
- Novartis$2K
- Kala Pharmaceuticals, Inc.$1K
- Sun Pharmaceutical Industries Inc.$822
- plus $4K from 14 others
What the payments were for
- Consulting fees$1,80012%
- Travel & lodging$3,02021%
- Food & beverage$9,63467%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 17 | $2,955 |
| Alcon | 44 | $1,894 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 17 | $1,873 |
| Novartis | 36 | $1,503 |
| Kala Pharmaceuticals, Inc. | 24 | $1,432 |
| Sun Pharmaceutical Industries Inc. | 18 | $822 |
| Coopervision Inc. | 18 | $752 |
| Johnson & Johnson Vision Care, Inc. | 11 | $521 |
| Oyster Point Pharma, Inc. | 8 | $381 |
| AbbVie(2 entities) | 14 | $359 |
| AstraZeneca | 3 | $337 |
| Shire North American Group Inc | 4 | $267 |
| Tarsus Pharmaceuticals, Inc. | 7 | $251 |
| Sanofi | 2 | $237 |
| Amgen | 3 | $225 |
| Dompe US, Inc. | 4 | $200 |
| Bausch & Lomb Americas Inc. | 5 | $169 |
| Eyevance Pharmaceuticals LLC | 1 | $143 |
| LKC Technologies, Inc. | 1 | $106 |
| Glaukos Corporation | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTRA$1,367
- BIOTRUE$1,232
- One Series Ultra IOL Delivery System$1,100
- EYSUVIS$1,095
- TearScience Lipiflow System$1,091
- TearScience Lipiview System$1,091
- TearScience Lipiscan System$1,091
- XIIDRA$910
- DAILIES$761
- AIR OPTIX$751
- CEQUA$578
- INFUSE$359
- INVELTYS$273
- DISEASE STATE$237
- Acuvue$229
- TYRVAYA$146
- Tobradex ST$143
- Multiple Brands Contact Lens$125
- BIOTRUE ONE DAY$123
- TRYPTYR$120
How this compares
$14,454 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 22 | $23,597 |
| RestasisCyclosporine | 20 | $16,572 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra | $169 | $23,59722 claims |
| AbbVieRestasis | $359 | $16,57220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,995 optometrist providers in Ohio.
Other optometrist in Cincinnati
- Carly RoseCincinnati$203K
- John LahrCincinnati$145K
- Mary YackeyCincinnati$122K
- Elliot KirsteinCincinnati$18K
- Todd ZelczakCincinnati$15K
- Mile BrujicBowling Green$1.3M
- Gregory DenaeyerColumbus$846K
- Cory LappinMontgomery$367K
- Chris SmileyColumbus$305K
- Thomas ChesterCleveland$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.